(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.17%) $0.928
(0.15%) $10.86
(-0.03%) $0.792
(-0.02%) $92.56
Live Chart Being Loaded With Signals
Hyundai Bioscience Co., Ltd., a biotechnology company, develops and commercializes bio-fusion technology for delivering active ingredients to human body...
Stats | |
---|---|
Today's Volume | 620 982 |
Average Volume | 478 034 |
Market Cap | 836.12B |
EPS | KRW0 ( 2024-02-25 ) |
Next earnings date | ( KRW0 ) 2024-05-13 |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | 0 |
ATR14 | KRW51.61 (0.25%) |
Volume Correlation
Hyundai Bioscience Co., Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Hyundai Bioscience Co., Correlation - Currency/Commodity
Hyundai Bioscience Co., Financials
Annual | 2023 |
Revenue: | KRW9.48B |
Gross Profit: | KRW3.92B (41.36 %) |
EPS: | KRW-364.53 |
Q4 | 2023 |
Revenue: | KRW1.13B |
Gross Profit: | KRW211.33M (18.64 %) |
EPS: | KRW-203.13 |
Q3 | 2023 |
Revenue: | KRW1.96B |
Gross Profit: | KRW769.59M (39.20 %) |
EPS: | KRW-49.72 |
Q2 | 2023 |
Revenue: | KRW3.22B |
Gross Profit: | KRW1.50B (46.45 %) |
EPS: | KRW-58.73 |
Financial Reports:
No articles found.
Hyundai Bioscience Co.,
Hyundai Bioscience Co., Ltd., a biotechnology company, develops and commercializes bio-fusion technology for delivering active ingredients to human body. The company provides Vitabrid C12, a new-conceptual vitamin C product that delivers active vitamin C into the skin. It also develops organic-inorganic hybrid technology, a drug delivery system technology that allows the selective and effective delivery of active substances on the target area in combination with bio-friendly minerals, as well as in anticancer drug carrier technology. The company was founded in 2000 and is based in Seoul, South Korea.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators